Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma

被引:371
作者
Challa-Malladi, Madhavi [1 ]
Lieu, Yen K. [1 ]
Califano, Olivia [1 ]
Holmes, Antony B. [1 ]
Bhagat, Govind [2 ,3 ]
Murty, Vundavalli V. [1 ,2 ,3 ]
Dominguez-Sola, David [1 ]
Pasqualucci, Laura [1 ,2 ,3 ]
Dalla-Favera, Riccardo [1 ,2 ,3 ,4 ,5 ]
机构
[1] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA
[3] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
[4] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA
[5] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA
关键词
MHC CLASS-I; ADHESION MOLECULES; HODGKIN-LYMPHOMA; T-LYMPHOCYTES; HEAVY-CHAINS; LFA-3; EXPRESSION; MUTATIONS; ANTIGEN; RECEPTOR;
D O I
10.1016/j.ccr.2011.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report that diffuse large B cell lymphoma (DLBCL) commonly fails to express cell-surface molecules necessary for the recognition of tumor cells by immune-effector cells. In 29% of cases, mutations and deletions inactivate the beta 2-Microglobulin gene, thus preventing the cell-surface expression of the HLA class-I (HLA-I) complex that is necessary for recognition by CD8(+) cytotoxic T cells. In 21 A) of cases, analogous lesions involve the CD58 gene, which encodes a molecule involved in T and natural killer cell-mediated responses. In addition to gene inactivation, alternative mechanisms lead to aberrant expression of HLA-I and CD58 in >60% of DLBCL. These two events are significantly associated in this disease, suggesting that they are coselected during lymphomagenesis for their combined role in escape from immune-surveillance.
引用
收藏
页码:728 / 740
页数:13
相关论文
共 50 条
[11]   ANCHORING MECHANISMS FOR LFA-3 CELL-ADHESION GLYCOPROTEIN AT MEMBRANE-SURFACE [J].
DUSTIN, ML ;
SELVARAJ, P ;
MATTALIANO, RJ ;
SPRINGER, TA .
NATURE, 1987, 329 (6142) :846-848
[12]   "Hard" and "soft" lesions underlying the HLA Class I alterations in cancer cells: implications for immunotherapy [J].
Garrido, Federico ;
Cabrera, Teresa ;
Aptsiauri, Natalia .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (02) :249-256
[13]   Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma [J].
Green, Michael R. ;
Monti, Stefano ;
Rodig, Scott J. ;
Juszczynski, Przemyslaw ;
Currie, Treeve ;
O'Donnell, Evan ;
Chapuy, Bjoern ;
Takeyama, Kunihiko ;
Neuberg, Donna ;
Golub, Todd R. ;
Kutok, Jeffery L. ;
Shipp, Margaret A. .
BLOOD, 2010, 116 (17) :3268-3277
[14]   Role of LFA-3, ICAM-1, and MHC class I on the of human tumor cells to LAK cells [J].
Gwin, JL ;
GercelTaylor, C ;
Taylor, DD ;
Eisenberg, B .
JOURNAL OF SURGICAL RESEARCH, 1996, 60 (01) :129-136
[15]   β2-microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma [J].
Hicklin, DJ ;
Wang, ZG ;
Arienti, F ;
Rivoltini, L ;
Parmiani, G ;
Ferrone, S .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (12) :2720-2729
[16]   The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile [J].
Huang, JZ ;
Sanger, WG ;
Greiner, TC ;
Staudt, LM ;
Weisenburger, DD ;
Pickering, DL ;
Lynch, JC ;
Armitage, JO ;
Wamke, RA ;
Alizadeh, AA ;
Lossos, IS ;
Levy, R ;
Chan, WC .
BLOOD, 2002, 99 (07) :2285-2290
[17]   Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome [J].
Hughes, EA ;
Hammond, C ;
Cresswell, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1896-1901
[18]   Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma [J].
Iqbal, J. ;
Greiner, T. C. ;
Patel, K. ;
Dave, B. J. ;
Smith, L. ;
Ji, J. ;
Wright, G. ;
Sanger, W. G. ;
Pickering, D. L. ;
Jain, S. ;
Horsman, D. E. ;
Shen, Y. ;
Fu, K. ;
Weisenburger, D. D. ;
Hans, C. P. ;
Campo, E. ;
Gascoyne, R. D. ;
Rosenwald, A. ;
Jaffe, E. S. ;
Delabie, J. ;
Rimsza, L. ;
Ott, G. ;
Mueller-Hermelink, H. K. ;
Connors, J. M. ;
Vose, J. M. ;
McKeithan, T. ;
Staudt, L. M. ;
Chan, W. C. .
LEUKEMIA, 2007, 21 (11) :2332-2343
[19]   β2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system [J].
Jordanova, ES ;
Riemersma, SA ;
Philippo, K ;
Schuuring, E ;
Kluin, PM .
INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (03) :393-398
[20]  
KANNER SB, 1992, J IMMUNOL, V148, P2023